Standout Papers

Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women... 2000 2026 2008 2017 740
  1. Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results (2000)
    M. Piccart JNCI Journal of the National Cancer Institute

Immediate Impact

6 from Science/Nature 70 standout
Sub-graph 1 of 20

Citing Papers

Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
2021 Standout
Challenges and Opportunities in Cancer Drug Resistance
2020 Standout
3 intermediate papers

Works of M. Piccart being referenced

Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results
2000 Standout
selection of Cancer Chemotherapy for a Patient by an In Vitro Assay Versus a Clinician
1990

Author Peers

Author Last Decade Papers Cites
M. Piccart 469 139 178 668 416 21 1.1k
Ann Marie Swart 426 107 165 876 438 21 1.2k
Eizo Kimura 363 77 202 735 381 20 1.1k
C. Tropé 370 100 125 874 449 11 1.1k
E. A. Eisenhauer 397 148 351 483 296 30 1.1k
Anderley Gordon 526 52 306 896 569 31 1.3k
F. Raja 482 158 285 761 225 10 1.1k
J. J. Kavanagh 393 171 307 531 300 50 1.2k
N. Einhorn 197 98 110 551 311 35 951
J. F. Pringle 481 248 156 353 358 22 1.3k
H.G. Meerpohl 398 74 153 346 287 26 1.1k

All Works

Loading papers...

Rankless by CCL
2026